Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Translucence Biosystems
January 31, 2023

Translucence Biosystems recently took part in the Keystone meeting, "Drug Delivery to the Brain: Challenges and Progress," which was held in Breckinridge, CO from January 23-26, 2023. Our team collaborated with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. The CEO of Translucence Biosystems, Damian Wheeler, Ph.D., presented the findings in a poster titled "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."

The Keystone meeting provided a valuable opportunity for Translucence Biosystems to network with industry leaders and stay informed about the latest advancements in drug delivery research. We are grateful for the support of event organizers, Robert Thorne from Denali Therapeutics and Reina Bendayan from the University of Toronto.

Download a copy of our poster here.

Ask your question

Send us your questions and we will get back to you as soon as possible

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

June 15, 2023

Highlights from the 9th Annual BRAIN Initiative Meeting

Translucence Biosystems recently participated in the 9th Annual BRAIN Initiative Meeting: Open Science, New Tools! The conference, held on June 12-13, 2023, aimed to foster a dynamic and collaborative research community through interactions among like-minded scientists who study the brain.
Angela Prvulovic
May 20, 2023

Co-Founder and CEO, Damian Wheeler Presents at KSNeurodegen23 on Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid

Co-Founder and CEO, Damian Wheeler, presented a poster titled "Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid" at the Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development conference hosted by the by Keystone Symposia on Molecular & Cellular Biology.
Angela Prvulovic
March 23, 2023

CEO, Damian Wheeler Ph.D., Presents at the BIO-SEE 2023 Webinar Series

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".
Translucence Biosystems